Merck
MRK
2,648 hedge funds and large institutions have $139B invested in Merck in 2021 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 1,239 increasing their positions, 980 reducing their positions, and 101 closing their positions.
71% more call options, than puts
Call options by funds: $2.93B | Put options by funds: $1.72B
26% more repeat investments, than reductions
Existing positions increased: 1,239 | Existing positions reduced: 980
12% more first-time investments, than exits
New positions opened: 113 | Existing positions closed: 101
2% more funds holding in top 10
Funds holding in top 10: 82 → 84 (+2)
0.53% less ownership
Funds ownership: 73.46% → 72.93% (-0.53%)
1% less funds holding
Funds holding: 2,674 → 2,648 (-26)
4% less capital invested
Capital invested by funds: $144B → $139B (-$5.57B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$433M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$256M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$238M |
| 4 |
Goldman Sachs
New York
|
+$219M |
| 5 |
Barclays
London,
United Kingdom
|
+$151M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.15B |
| 2 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$712M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$456M |
| 4 |
KBC Group
Brussels,
Belgium
|
-$297M |
| 5 |
JP Morgan Chase
New York
|
-$283M |
MRK Hedge Fund Activity: Q3 2021 in Review
2,648 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2021, worth a combined $139B — down 3.9% from $144B a quarter earlier.
Buyers outnumbered sellers: 113 funds opened new MRK positions and 101 closed out — a net gain of 12 holders — while 1,239 added to existing stakes and 980 trimmed.
The largest buyer was Invesco, adding an estimated $433M. The largest seller was Vanguard Group, cutting an estimated $1.15B.
- 2,648 institutional investors held Merck (MRK) as of Q3 2021, down from 2,674 in Q2 2021.
- Funds reported $139B of Merck stock for Q3 2021, down 3.9% quarter-over-quarter.
- 113 funds opened new Merck positions in Q3 2021 and 101 closed out, a net change of +12 holders.
- The largest Merck buyer in Q3 2021 was Invesco, an estimated $433M added.
- The largest Merck seller in Q3 2021 was Vanguard Group, an estimated $1.15B sold.
Based on aggregated 13F filings for Q3 2021.